 |
October 21, 2009
CGPA Statement Regarding Proposed Legislative Amendments
to Canada’s Access to Medicines Regime |
|
| The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding two Private Members’ Bills proposing significant improvements to Canada’s Access to Medicines Regime (CAMR): | read more... |
|
September 28, 2009
Canada Welcoming World’s Generic Pharmaceutical Industry
Canada hosting 12th Annual International Generic Pharmaceutical Alliance (IGPA)
Conference – Montréal, September 30 – October 2, 2009 |
|
| Canada is hosting the 12th Annual International Generic Pharmaceutical Alliance (IGPA) Conference in Montréal from September 30 through October 2, 2009, the first time the event has been held in Canada. | read more... |
|
August 12, 2009
Federal Drug Watchdog Report: Brand-Name Drug Makers Break R&D Spending Promise for Eighth Consecutive Year
Only 1.2% of Canadian sales revenues directed to new medicine discovery |
|
| For the eighth consecutive year, brand-name drug companies have broken their promise to spend at least 10 per cent of their Canadian sales on research and development in Canada, according to the recently released annual report of the Patented Medicine Prices Review Board (PMPRB). | read more... |
|
July 22, 2009
Federal Court Decision on Extended Monopolies for Big Pharma will Cost Canadians More than $100 Million Per Year |
|
| The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the July 17, 2009 decision of the Federal Court of Canada regarding extended market monopolies for Big Pharma. | read more... |
|
April 27, 2009
Statement from the Canadian Generic Pharmaceutical Association (CGPA) Regarding Ontario Legal Action |
|
| The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding today’s announcement by the Government of Ontario that it is taking legal action against a number of pharmacies, generic drug manufacturers and wholesalers. | read more... |
|
April 23, 2009
First Subsequent Entry Biologic Approved in Canada
CGPA welcomes competition to Canadian market for biologic medicines |
|
| The Canadian Generic Pharmaceutical Association (CGPA) today welcomed the first ever approval of a subsequent entry biologic (SEB) in Canada and urged Health Canada to move forward with the completion of its SEB guidance without further delay. | read more... |
|
March 26, 2009
Generic Drugs Now Fill Majority of Canadian Prescriptions
Generic medications filled 51.6% of all prescriptions for only 23% of $21.4-billion Canadians spent on Prescription Drugs in 2008 |
|
| For the first time in Canadian history, generic medicines now fill the majority of prescriptions in Canada. According to sales data released today by IMS Health Canada, the world leader in prescription drug sales information, generic drugs were dispensed to fill 51.6 percent of all prescriptions in Canada in 2008 yet accounted for only 23 percent of the $21.4-billion spent on prescription medicines. | read more... |
|
March 26, 2009
Generic Drugs Now Fill Majority of Canadian Prescriptions
Generic medications filled 51.6% of all prescriptions for only 23% of $21.4-billion Canadians spent on Prescription Drugs in 2008 |
|
| For the first time in Canadian history, generic medicines now fill the majority of prescriptions in Canada. According to sales data released today by IMS Health Canada, the world leader in prescription drug sales information, generic drugs were dispensed to fill 51.6 percent of all prescriptions in Canada in 2008 yet accounted for only 23 percent of the $21.4-billion spent on prescription medicines. | read more... |
|
March 2, 2009
CGPA Welcomes President Obama's Support for Generic Biologics: Urges Canadian Government to Implement Approval Pathway |
|
| The Canadian Generic Pharmaceutical Association (CGPA) today urged the Government of Canada to follow United States President Barack Obama's budget proposal and implement an approval pathway for generic biologic drugs. | read more... |
|
January 8, 2009
Pierre Fréchette Elected Chair of Canadian Generic Pharmaceutical Association |
|
| The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the election of Pierre Fréchette, President and Chief Executive Officer of Sandoz Canada, as Chair of CGPA. | read more... |
|
| |
|
TOP |
| |
|
|
